SpaceX is reportedly planning a $75 billion IPO at $135 per share, potentially valuing the company at around $1.75 trillion. According to reports from Kotak News Desk, the IPO could become one of the biggest IPOs in global market history, with roughly 555.6 million shares being offered as part of the transaction. The company is preparing to enter investor roadshow discussions soon, with discussions with investors expected to begin soon. A notable feature of this potential offering is that SpaceX could enter its investor roadshow with a pre-determined price rather than the usual price band used by most IPOs. Reports suggest that as much as 30% of the issue could be earmarked for retail participants, which would be significantly higher than what is generally seen in large public offerings. The IPO is expected to be structured as a fresh issue, meaning the funds raised would go directly to the company, with existing shareholders not expected to offload stock through the proposed offering.
Hexagon Nutrition IPO is a book-build issue worth ₹138.87 crore consisting entirely of an offer for sale of 30.90 million shares. The bidding window opened on June 5, 2026 and closed on June 9, 2026, with the issue achieving exceptional investor response and being subscribed 54 times. The issue received bids for 1,15,96,08,897 shares against the 2,16,02,008 shares on offer, demonstrating strong market demand. The issue is priced in the ₹42-45 per share band with retail investors requiring a minimum investment of ₹14,985 for 333 shares at the upper cap. The issue has been subscribed 1.65 times across categories, with retail individual investors and non-institutional investors booking their quotas at 2.42 times and 2.03 times respectively, while qualified institutional buyers have placed no bids so far. The company raised ₹41.65 crore from anchor investors on June 4, 2026, with the board allotting 92.57 lakh shares at ₹45 each to 5 anchor investors. Founded in 1993, the company develops and manufactures clinical nutrition products, branded wellness supplements, and micronutrient premixes for global FMCG brands, operating manufacturing facilities in India and Uzbekistan and exporting to over 75 countries.
NLC India's offer for sale (OFS) garnered robust demand from institutional investors on Tuesday, prompting the government to fully exercise the greenshoe option. According to stock exchange data, bids were received for nearly 130 million shares, 3.1 times the total 41.6 million shares on offer. Most bids were concentrated around ₹323 per share, compared with the floor price of ₹303. The strong demand enabled the Centre to divest a 3% stake and raise about ₹1,365 crore. Prior to the stake sale, the government held a 72% stake in the lignite miner. Shares of NLC India ended at ₹327.85 in secondary market trading. The stake sale is part of the government's ongoing disinvestment programme and follows similar OFS transactions in state-run companies such as NHPC and Coal India.
The National Stock Exchange (NSE) announced on Tuesday that it will earmark 10% of its annual corporate social responsibility (CSR) corpus for deployment through projects listed on the NSE Social Stock Exchange (SSE). The announcement follows a recent regulatory change that allows companies to channel their CSR expenditure through subscriptions to Zero Coupon Zero Principal (ZCZP) instruments listed on SSEs. NSE stated that deploying a portion of its own CSR corpus through the SSE could encourage broader institutional participation and support innovative social-financing mechanisms. This initiative signals NSE's commitment to promoting social impact investing and supporting the development of the Social Stock Exchange platform.
The primary market will remain active during June 8-12, 2026, with two mainboard listings and the closing of four SME IPO bidding windows. According to reports from Essential Business Intelligence, this week's IPO activity includes both fresh issues and offer for sale structures across different market segments, with the market gaining momentum after a period of low activity in the mainboard IPO segment. The strong response from Hexagon Nutrition's IPO, achieving 54 times subscription, makes it the second consecutive mainboard IPO to attract robust investor interest, signalling improving sentiment in the primary market.
